Holdings (Monthly)
Guide ↗
Putnam Global Health Care Fund
| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | 532457108 | Feb 2026 | 174,220 | +2,880 | $192.5M | +6.8% | 13.15% | EC |
| 2 | Johnson & Johnson | 478160104 | Feb 2026 | 550,143 | -19,800 | $124.0M | -12.4% | 8.46% | EC |
| 3 | UnitedHealth Group, Inc. | 91324P102 | Feb 2026 | 266,960 | — | $101.5M | +29.7% | 6.93% | EC |
| 4 | AbbVie, Inc. | 00287Y109 | Feb 2026 | 406,900 | — | $88.6M | -6.2% | 6.05% | EC |
| 5 | Novartis AG | N/A | Feb 2026 | 499,771 | +385,871 | $75.2M | +1761.2% | 5.13% | EC |
| 6 | Merck & Co., Inc. | 58933Y105 | Feb 2026 | 601,971 | -82,700 | $71.5M | -15.7% | 4.88% | EC |
| 7 | AstraZeneca plc | N/A | Feb 2026 | 368,545 | NEW | $68.4M | — | 4.67% | EC |
| 8 | Thermo Fisher Scientific, Inc. | 883556102 | Feb 2026 | 133,880 | +20,960 | $65.9M | +12.1% | 4.50% | EC |
| 9 | Intuitive Surgical, Inc. | 46120E602 | Feb 2026 | 139,340 | +16,320 | $59.2M | -4.5% | 4.04% | EC |
| 10 | Sanofi SA | N/A | Feb 2026 | 540,411 | NEW | $47.4M | — | 3.23% | EC |
| 11 | Edwards Lifesciences Corp. | 28176E108 | Feb 2026 | 474,800 | +176,300 | $41.1M | +59.1% | 2.80% | EC |
| 12 | Roche Holding AG | N/A | Feb 2026 | 97,154 | NEW | $40.9M | — | 2.79% | EC |
| 13 | CVS Health Corp. | 126650100 | Feb 2026 | 440,300 | +74,000 | $40.1M | +36.9% | 2.74% | EC |
| 14 | Gilead Sciences, Inc. | 375558103 | Feb 2026 | 286,000 | — | $38.4M | -9.7% | 2.63% | EC |
| 15 | McKesson Corp. | 58155Q103 | Feb 2026 | 42,240 | — | $31.4M | -24.8% | 2.14% | EC |
| 16 | Cardinal Health, Inc. | 14149Y108 | Feb 2026 | 157,400 | — | $31.0M | -14.1% | 2.12% | EC |
| 17 | Vertex Pharmaceuticals, Inc. | 92532F100 | Feb 2026 | 64,340 | -9,520 | $28.8M | -21.5% | 1.97% | EC |
| 18 | Novo Nordisk A/S | N/A | Feb 2026 | 609,968 | NEW | $27.9M | — | 1.90% | EC |
| 19 | Boston Scientific Corp. | 101137107 | Feb 2026 | 546,348 | -40,900 | $26.4M | -41.5% | 1.80% | EC |
| 20 | Bristol-Myers Squibb Co. | 110122108 | Feb 2026 | 448,200 | -82,000 | $25.6M | -22.5% | 1.75% | EC |
| 21 | Dexcom, Inc. | 252131107 | May 2026 | 325,000 | NEW | $24.0M | — | 1.64% | EC |
| 22 | Hoya Corp. | N/A | Feb 2026 | 130,800 | NEW | $22.2M | — | 1.52% | EC |
| 23 | Putnam Short Term Investment Fund | 74676P664 | Feb 2026 | 19,825,753 | -1,236,412 | $19.8M | -5.9% | 1.35% | — |
| 24 | HCA Healthcare, Inc. | 40412C101 | Feb 2026 | 45,780 | — | $17.3M | -28.5% | 1.18% | EC |
| 25 | Amgen, Inc. | 031162100 | May 2026 | 48,160 | NEW | $16.2M | — | 1.11% | EC |
| 26 | Waters Corp. | 941848103 | May 2026 | 39,280 | NEW | $15.1M | — | 1.03% | EC |
| 27 | Argenx SE | N/A | Feb 2026 | 16,189 | NEW | $13.5M | — | 0.92% | EC |
| 28 | GSK plc | N/A | Feb 2026 | 509,032 | NEW | $12.9M | — | 0.88% | EC |
| 29 | Royalty Pharma plc | N/A | Feb 2026 | 223,000 | NEW | $12.4M | — | 0.85% | EC |
| 30 | Chugai Pharmaceutical Co. Ltd. | N/A | Feb 2026 | 246,100 | NEW | $12.2M | — | 0.83% | EC |
| 31 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Feb 2026 | 19,538 | -5,480 | $12.0M | -38.6% | 0.82% | EC |
| 32 | Insmed, Inc. | 457669307 | Feb 2026 | 89,900 | — | $9.6M | -28.4% | 0.66% | EC |
| 33 | United Therapeutics Corp. | 91307C102 | May 2026 | 15,840 | NEW | $8.8M | — | 0.60% | EC |
| 34 | Xenon Pharmaceuticals, Inc. | 98420N105 | May 2026 | 134,200 | NEW | $7.3M | — | 0.50% | EC |
| 35 | Apogee Therapeutics, Inc. | 03770N101 | May 2026 | 88,000 | NEW | $7.2M | — | 0.49% | EC |
| 36 | Ascendis Pharma A/S | N/A | Feb 2026 | 31,488 | NEW | $7.1M | — | 0.48% | EC |
| 37 | Rhythm Pharmaceuticals, Inc. | 76243J105 | Feb 2026 | 76,900 | -30,900 | $6.8M | -32.1% | 0.46% | EC |
| 38 | Putnam Cash Collateral Pool LLC | 99311N9A5 | Feb 2026 | 6,383,950 | +3,980,416 | $6.4M | +165.6% | 0.44% | STIV |
| 39 | Cytokinetics, Inc. | 23282W605 | May 2026 | 54,500 | NEW | $4.2M | — | 0.29% | EC |
| 40 | Newamsterdam Pharma Co. NV | N/A | Feb 2026 | 120,500 | NEW | $4.1M | — | 0.28% | EC |
| 41 | United States of America | 912797TN7 | Feb 2026 | 2,500,000 | +600,000 | $2.5M | +32.8% | 0.17% | STIV |
| 42 | N/A | N/A | Feb 2026 | 1 | NEW | $602K | — | 0.04% | DFE |
| 43 | N/A | N/A | Feb 2026 | 1 | NEW | $450K | — | 0.03% | DFE |
| 44 | N/A | N/A | Feb 2026 | 1 | NEW | $381K | — | 0.03% | DFE |
| 45 | N/A | N/A | Feb 2026 | 1 | NEW | $301K | — | 0.02% | DFE |
| 46 | N/A | N/A | Feb 2026 | 1 | NEW | $217K | — | 0.01% | DFE |
| 47 | N/A | N/A | Feb 2026 | 1 | NEW | $196K | — | 0.01% | DFE |
| 48 | N/A | N/A | Feb 2026 | 1 | NEW | $163K | — | 0.01% | DFE |
| 49 | N/A | N/A | Feb 2026 | 1 | NEW | $141K | — | 0.01% | DFE |
| 50 | N/A | N/A | Feb 2026 | 1 | NEW | $112K | — | 0.01% | DFE |
| 51 | N/A | N/A | Feb 2026 | 1 | NEW | $110K | — | 0.01% | DFE |
| 52 | N/A | N/A | Feb 2026 | 1 | NEW | $97K | — | 0.01% | DFE |
| 53 | N/A | N/A | Feb 2026 | 1 | NEW | $87K | — | 0.01% | DFE |
| 54 | N/A | N/A | Feb 2026 | 1 | NEW | $78K | — | 0.01% | DFE |
| 55 | N/A | N/A | Feb 2026 | 1 | NEW | $74K | — | 0.01% | DFE |
| 56 | N/A | N/A | Feb 2026 | 1 | NEW | $63K | — | 0.00% | DFE |
| 57 | N/A | N/A | Feb 2026 | 16,954,400 | NEW | $59K | — | 0.00% | DE |
| 58 | N/A | N/A | Feb 2026 | 1 | NEW | $58K | — | 0.00% | DFE |
| 59 | N/A | N/A | Feb 2026 | 1 | NEW | $56K | — | 0.00% | DFE |
| 60 | N/A | N/A | Feb 2026 | 1 | NEW | $54K | — | 0.00% | DFE |
| 61 | N/A | N/A | Feb 2026 | 1 | NEW | $51K | — | 0.00% | DFE |
| 62 | N/A | N/A | Feb 2026 | 1 | NEW | $41K | — | 0.00% | DFE |
| 63 | N/A | N/A | Feb 2026 | 1 | NEW | $38K | — | 0.00% | DFE |
| 64 | N/A | N/A | Feb 2026 | 1 | NEW | $36K | — | 0.00% | DFE |
| 65 | N/A | N/A | Feb 2026 | 1 | NEW | $31K | — | 0.00% | DFE |
| 66 | N/A | N/A | Feb 2026 | 1 | NEW | $26K | — | 0.00% | DFE |
| 67 | N/A | N/A | Feb 2026 | 1 | NEW | $25K | — | 0.00% | DFE |
| 68 | N/A | N/A | Feb 2026 | 1 | NEW | $24K | — | 0.00% | DFE |
| 69 | N/A | N/A | Feb 2026 | 1 | NEW | $24K | — | 0.00% | DFE |
| 70 | N/A | N/A | Feb 2026 | 1 | NEW | $22K | — | 0.00% | DFE |
| 71 | N/A | N/A | Feb 2026 | 1 | NEW | $20K | — | 0.00% | DFE |
| 72 | N/A | N/A | Feb 2026 | 1 | NEW | $11K | — | 0.00% | DFE |
| 73 | N/A | N/A | Feb 2026 | 1 | NEW | $8K | — | 0.00% | DFE |
| 74 | N/A | N/A | Feb 2026 | 1 | NEW | $2K | — | 0.00% | DFE |
| 75 | N/A | N/A | Feb 2026 | 1 | NEW | $2K | — | 0.00% | DFE |
| 76 | N/A | N/A | Feb 2026 | 1 | NEW | $932 | — | 0.00% | DFE |
| 77 | Australian Dollar | N/A | Feb 2026 | 1,023 | NEW | $735 | — | 0.00% | STIV |
| 78 | EURO | N/A | Feb 2026 | 1 | NEW | $1 | — | 0.00% | STIV |
| 79 | Danish Krone | N/A | Feb 2026 | 0 | NEW | $0 | — | 0.00% | STIV |
| 80 | Swiss Franc | N/A | Feb 2026 | -0 | NEW | $-0 | — | 0.00% | STIV |
| 81 | N/A | N/A | Feb 2026 | 1 | NEW | $-40 | — | -0.00% | DFE |
| 82 | N/A | N/A | Feb 2026 | 1 | NEW | $-933 | — | -0.00% | DFE |
| 83 | N/A | N/A | Feb 2026 | 1 | NEW | $-3177 | — | -0.00% | DFE |
| 84 | N/A | N/A | Feb 2026 | 1 | NEW | $-3939 | — | -0.00% | DFE |
| 85 | N/A | N/A | Feb 2026 | 1 | NEW | $-5053 | — | -0.00% | DFE |
| 86 | N/A | N/A | Feb 2026 | 1 | NEW | $-17454 | — | -0.00% | DFE |
| 87 | N/A | N/A | Feb 2026 | 1 | NEW | $-17469 | — | -0.00% | DFE |
| 88 | N/A | N/A | Feb 2026 | 1 | NEW | $-21020 | — | -0.00% | DFE |
| 89 | N/A | N/A | Feb 2026 | 1 | NEW | $-23729 | — | -0.00% | DFE |
| 90 | N/A | N/A | Feb 2026 | 1 | NEW | $-24396 | — | -0.00% | DFE |
| 91 | N/A | N/A | Feb 2026 | 1 | NEW | $-38929 | — | -0.00% | DFE |
| 92 | N/A | N/A | Feb 2026 | 1 | NEW | $-47040 | — | -0.00% | DFE |
| 93 | N/A | N/A | Feb 2026 | 1 | NEW | $-48651 | — | -0.00% | DFE |
| 94 | N/A | N/A | Feb 2026 | 1 | NEW | $-49637 | — | -0.00% | DFE |
| 95 | N/A | N/A | Feb 2026 | 1 | NEW | $-52403 | — | -0.00% | DFE |
| 96 | N/A | N/A | Feb 2026 | 1 | NEW | $-52751 | — | -0.00% | DFE |
| 97 | N/A | N/A | Feb 2026 | 1 | NEW | $-61982 | — | -0.00% | DFE |
| 98 | N/A | N/A | Feb 2026 | 1 | NEW | $-70478 | — | -0.00% | DFE |
| 99 | N/A | N/A | Feb 2026 | 1 | NEW | $-70498 | — | -0.00% | DFE |
| 100 | N/A | N/A | Feb 2026 | 1 | NEW | $-75130 | — | -0.01% | DFE |
| 101 | N/A | N/A | Feb 2026 | 1 | NEW | $-75591 | — | -0.01% | DFE |
| 102 | N/A | N/A | Feb 2026 | 1 | NEW | $-80742 | — | -0.01% | DFE |
| 103 | N/A | N/A | Feb 2026 | 1 | NEW | $-92104 | — | -0.01% | DFE |
| 104 | N/A | N/A | Feb 2026 | 1 | NEW | $-114647 | — | -0.01% | DFE |
| 105 | N/A | N/A | Feb 2026 | 1 | NEW | $-117565 | — | -0.01% | DFE |
| 106 | N/A | N/A | Feb 2026 | 1 | NEW | $-118384 | — | -0.01% | DFE |
| 107 | N/A | N/A | Feb 2026 | 1 | NEW | $-132012 | — | -0.01% | DFE |
| 108 | N/A | N/A | Feb 2026 | 1 | NEW | $-134355 | — | -0.01% | DFE |
| 109 | N/A | N/A | Feb 2026 | 1 | NEW | $-134388 | — | -0.01% | DFE |
| 110 | N/A | N/A | Feb 2026 | 1 | NEW | $-139513 | — | -0.01% | DFE |
| 111 | N/A | N/A | Feb 2026 | 1 | NEW | $-142574 | — | -0.01% | DFE |
| 112 | N/A | N/A | Feb 2026 | 1 | NEW | $-154753 | — | -0.01% | DFE |
| 113 | N/A | N/A | Feb 2026 | 1 | NEW | $-269087 | — | -0.02% | DFE |
| 114 | N/A | N/A | Feb 2026 | 1 | NEW | $-276669 | — | -0.02% | DFE |
| 115 | N/A | N/A | Feb 2026 | 1 | NEW | $-545248 | — | -0.04% | DFE |
| ✕ | Ascendis Pharma A/S | 04351P101 | — | 113,788 | SOLD | $26.6M | — | — | — |
| ✕ | Alnylam Pharmaceuticals, Inc. | 02043Q107 | — | 62,800 | SOLD | $20.9M | — | — | — |
| ✕ | Abbott Laboratories | 002824100 | — | 135,900 | SOLD | $15.8M | — | — | — |
| ✕ | Becton Dickinson & Co. | 075887109 | — | 88,700 | SOLD | $15.7M | — | — | — |
| ✕ | Vaxcyte, Inc. | 92243G108 | — | 228,000 | SOLD | $14.1M | — | — | — |
| ✕ | Precigen, Inc. | 74017N105 | — | 910,700 | SOLD | $3.5M | — | — | — |
| ✕ | United States of America | 912797SM0 | — | 500,000 | SOLD | $0.5M | — | — | — |